“Joe Zuraw has been a friend to the Alpha-1 Community for more than 20 years, he has worked tirelessly on behalf of patients his entire career. This honor could not be a better tribute to both Joe and also towards the John W. Walsh Translational Research Award....
FOR IMMEDIATE RELEASE November 2, 2020- The Alpha-1 Foundation is proud to announce the establishment of the Alpha-1 Foundation Therapeutic Development Network (TDN). The Alpha-1 TDN is a collaborative group comprised of the top specialists, researchers and our...
Miami, October 30, 2020 – Each year, the Alpha-1 Foundation recognizes November as Alpha-1 Awareness Month in order to raise awareness for Alpha-1 Antitrypsin Deficiency (Alpha-1) around the United States. This special month is commemorated by the wide variety of...
August 18, 2020 The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) has announced the award of a large rare disease grant which will focus on Alpha-1 Antitrypsin Deficiency. The grant entitled Alpha-1 Antitrypsin Disease Cohort:...
For Immediate Release April 1, 2020 -Alphas on Medicare have a new Choice! The Centers for Medicare and Medicaid Services Announced Sweeping Regulatory Changes that include an option for Alpha-1 patients to receive home infusions. These temporary changes will ensure...
